Scientist.com and antibodies-online.com Launch Product Hub, a One-Stop-Shop for Antibodies, ELISA Kits and Proteins
Scientist.com, the marketplace for outsourced research, and antibodies-online.com, the marketplace for research reagents, announced today the launch of the Antibody and Protein Product Hub, a one-stop-shop for off-the-shelf antibodies, ELISA kits, proteins and related reagents. Scientist.com marketplace users can now purchase from the world’s largest catalog of high-quality antibodies, ELISA kits, proteins and related reagents.
“Researchers want to find antibodies that work; they want to get them in an ‘amazon-like’ shopping experience; and they want antibody experts that support them all the way," said Tim Hiddemann, PhD, Managing Director and Co-Founder of antibodies-online.com. “We are very excited to partner with Scientist.com as researchers can now access and purchase custom research services and off-the-shelf research reagents in one place.”
Antibodies are a key tool in drug discovery research due to their high specificity and affinity and because they are amenable to rapid protein engineering. Antibodies have been engineered for use in a broad range of assays that quantitate, localize or modulate the activity of drug targets. With millions of antibodies now available, it has become difficult for researchers to find the right antibody for their drug project.
“Antibodies are the experimental work horses of life science research, playing an important role in almost all medical research breakthroughs,” said Romila Mukerjea, PhD, Scientist.com Antibody Director. “This partnership with antibodies-online.com creates a one-stop-shop of over 2 million antibodies with associated product data (supplier-provided, literature-based and crowd-sourced) and direct access to antibody experts in the US and Europe.”
Scientist.com is the world's leading marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saving time and money, reducing risk and providing access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit Scientist.com to learn more.
antibodies-online.com operates the largest Online Marketplace for off-the shelf Research Reagents, offering nearly 2 million Research Antibodies, ELISA Kits, Proteins and related products from over 250 suppliers. Founded in 2006 antibodies-online.com has shipped hundreds of thousands of products from its global supplier base to more than 6.000 research institutions in 65 countries. With teams located in the U.S. and Europe antibodies-online.com helps scientists find everything they need when they work on the protein level. antibodies-online.com has also put hundreds of different reagents into the hands of capable scientists to obtain additional data on the performance of these products under their Independent Validation Program.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-QUANERGY-SYSTEMS18.7.2019 21:02:06 CEST | Press release
Quanergy and Chery Established Partnership to Propel a New Era of Autonomous Vehicles and Smart Cities
LARSEN-&-TOUBRO-INFOTECH18.7.2019 18:10:08 CEST | Press release
LTI USD Revenue Growth up 11.5% YoY; Digital Revenues at 39%
NY-MOODY’S-ANALYTICS18.7.2019 17:32:06 CEST | Press release
Moody’s Analytics Wins Wholesale Modelling Software of the Year at Risk Technology Awards
FABASOFT18.7.2019 16:41:12 CEST | Press release
Fabasoft is a “Strong Performer” for Cloud Content Platforms, Q3 2019
CA-GILEAD-SCIENCES,-INC.18.7.2019 14:32:06 CEST | Press release
Gilead to Present New Data on HIV Prevention, Treatment and Cure Research at IAS 2019
BOEHRINGER-INGELHEIM18.7.2019 14:03:04 CEST | Press release
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom